INTRODUCTION
Generalized eruptive histiocytoma (GEH) is an extremely rare and benign proliferative disorder of the skin, affecting mainly adults. 1 It was first described in 1963 by Winkelmann and Müller. 2 It is currently classified by the Histiocytosis International Society as a non-Langerhans cells histiocytosis (NLCH) and it is also known as histiocytosis non-X, or class II. 3, 4 GEH is characterized by multiple asymptomatic and symmetrically distributed brownish erythematous papules particularly involving the axial regions as trunk, face and proximal extremities. The mucous membranes and viscera are usually spared. 3, 5, 6 The diagnosis is made by histopathological and immunohistochemical exams and the differential diagnosis includes Langerhans cell histiocytosis, urticaria pigmentosa and other NLCH.
Since the disease is extremely rare, studies are difficult to perform, limiting the understanding of the disease and therapeutic options. We present this case in order to improve the understanding of the disease and increase the interest of researchers.
CASE REPORT
A 79-year-old white man from Alagoas presented with a two-month-history of multiple asymptomatic disseminated erythematous papules. The dermatological examination showed erythematous papules, symmetrically distributed and widespread on the tegument, some in clusters, more evident on the dorsal aspect of the trunk and limbs (Figures 1  and 2 ). The scalp, mucous membranes, palms and soles were spared. The patient had no systemic signs or symptoms, and lesion sensitivity was preserved.
Considering the differential diagnosis of syphilis and leprosy, specific laboratory tests were performed and the results were negative. Skin biopsy showed dense mononuclear dermal infiltrate without atypia, occupying the entire dermis, and perivascular lymphocyte clusters on the superficial dermis (Figure 3 ). Wade staining was negative. The immunohistochemical examination was positive only for CD68 and negative for CD1a, CD34 and S100 (Figure 4) .
The diagnosis of GEH was based on the association of clinical, histopathological and immunohistochemical findings. The lesions regressed spontaneously after two months and he has no history of recurrence to date. 
DISCUSSION
Histiocytoses represent a group of proliferative disorders of the mononuclear phagocyte and immunoregulatory effector system (M-PIRE) composed by macrophages and dendritic cells. 6 The macrophages constitute the phagocytic function and the dendritic cells, represented by Langerhans cells, indeterminate cells and the dermal dendrocytes, constitute the antigens presentation. 3, 6 In 1987 the ''Writing Group of the Histiocyte Society'' presented the first classification of histiocytoses. Revised in 1997, this classification was divided into three classes: class I -dendritic cell-related histiocytosis (including Langerhans cell histiocytosis), class II -macrophage related histiocytosis and class III -malignant histiocytosis with monocyte infiltration. 1, 3 GEH is a benign and rare type of NLCH, characterized by brownish or reddish grouped papules, symmetrically distributed on the face, trunk and proximal extremities, frequently evolving to flares. The lesions are rarely seen on the mucous membranes. They tend to resolve spontaneously, and may regress with some residual hyperchromic macules. 3, 5, 7, 8 The disorder primarily affects adults, but it can also affect children in rare instances. The differential diagnosis among the NLCH is based primarily on the duration and course of lesions, patient age and presence or absence of associated systemic diseases. 4 Bringing together the clinical, histopathological and immunohistochemical findings, the diagnosis of our patient was compatible with GEH.
Negative immunohistochemistry results for CD1a, CD34 and S100 markers and the absence of Birbeck granules rule out the diagnosis of Langerhans cell histiocytosis.4 Benign Cephalic Histiocytosis is characterized by childhood onset and involvement of the face and upper trunk, representing a different pattern in comparison with that of our patient. Papular xanthoma, disseminated xanthoma (DX) and juvenile xanthogranuloma (JXG) were not considered as possible diagnoses for our patient, because of the color of the lesions and the absence of Touton giant cells. 6, 9 Recent medical literature has suggested that GEH may be considered as the initial spectrum for several histiocytoses, mainly for sharing clinical and immunophenotypical similarities. 4, 5, 9 GEH is an early undifferentiated stage of various histiocytic disorders. It may precede the classical presentation of JXG, DX, progressive nodular histiocytosis and/or multicentric reticulohistiocytosis. 5, 8, 9 It is occasionally associated with neoplasias such as cutaneous T-cell lymphoma and acute monocytic leukemia.
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As previously mentioned, the disease is self-limiting and does not produce systemic symptoms, therefore there is no need for treatment. 3, 7, 8 Lan et al. observed partial regression of lesions after 10 sessions of PUVA therapy, leaving some hyperpigmented papules and at the end of 20 sessions, there was complete regression without recurrence.
1 Kwinter et al. used oral isotretinoin in patients with a three-month evolution of GEH, which resulted in resolution of the disease without recurrence over eight months of treatment, although new lesions have appeared later. 10 Monitoring is recommended due to case reports of patients who developed other severe forms of histiocytosis, such as disseminated xanthoma.
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Considering the above facts, the authors conclude that non-Langerhans cell histiocytoses represent a field with few studies in dermatology, being limited to few reported cases, demanding the evaluation of therapeutic possibilities and the performation of randomized trials. ❑
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